×
About 16,178 results

Rituximab Raises Remission Rate in GPA Vasculitis
https://www.medscape.com/viewarticle/984760

Nov 30th, 2022 - More patients with granulomatosis with polyangiitis (GPA) were in remission at 6 months if they had received rituximab (Rituxan) rather than cyclophosphamide (Cytoxan) as induction therapy, according to a target trial emulation performed by the French Vasculitis Study Group (FVSG). Remission, which was defined as a score of zero on the validated Birmingham Vasculitis Activity Score (BVAS) and u...

Elderly Now Account for Almost 90% of COVID-19 Deaths, Data Show
https://www.medscape.com/viewarticle/984771

Nov 30th, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Almost 9 out of 10 COVID-19 deaths are among people 65 and older -- the highest rate yet for elderly fatalities since the pandemic began, according to an analysis by The Washington Post. The Centers for Disease Control says more than 300 people die each day from COVID-19 – down from the 2,000 or...

Researchers Take Aim at One Vaccine Targeting COVID, Flu, Even RSV
https://www.medscape.com/viewarticle/984795

Nov 30th, 2022 - With multiple viruses circulating around the United States and multiple vaccines to try to prevent some of them, there is increasing effort to streamline and improve the process and ultimately make one vaccine to attack most — if not all — of the viruses at the same time. Scientists are trying several approaches to stay ahead of not only influenza and SARS-Cov-2, but also respiratory syncytial ...

Germany Working to Ensure Continued Cooperation Between BioNTech, Chinese Partner
https://www.medscape.com/viewarticle/984620

Nov 29th, 2022 - BERLIN (Reuters) - Germany is working to ensure cooperation between BioNTech and its Chinese partner on the COVID-19 vaccine moves forward, a German government spokesperson said on Monday. German Chancellor Olaf Scholz announced an agreement earlier this month to let expatriates in China use the COVID-19 vaccine from Germany's BioNTech on his first visit to China since becoming chancellor. The ...

COVID No Longer 'Pandemic of the Unvaccinated'
https://www.medscape.com/viewarticle/984633

Nov 28th, 2022 - For the first time, the majority of people dying from COVID-19 in America have been vaccinated. "We can no longer say this is a pandemic of the unvaccinated," Kaiser Family Foundation Vice President Cynthia Cox, who conducted the analysis, told The Washington Post . People who had been vaccinated or boosted made up 58% of COVID-19 deaths in August, the analysis showed. The rate has been on the ...

Shionogi Seeks Japan Approval for COVID-19 Vaccine
https://www.medscape.com/viewarticle/984577

Nov 28th, 2022 - TOKYO (Reuters) - Shionogi & Co Ltd said on Thursday it had filed for approval in Japan of its experimental COVID-19 vaccine. The move comes two days after Japanese regulators granted emergency approval for Shionogi's oral treatment for COVID, the first for a domestic drugmaker. The filing for the recombinant protein-based vaccine, known as S-268019, was based on results from five clinical tria...

Uganda Recording Downward Trend in Ebola Cases: Official
https://www.medscape.com/viewarticle/984578

Nov 28th, 2022 - KAMPALA (Reuters) - Uganda has recorded a drop in the number of new Ebola cases, with some districts going for at least two weeks without registering new infections, health ministry officials said. The development is a major sign the East African country is having a measure of success in efforts to combat its latest outbreak of the deadly haemorrhagic fever disease more than two months after it...

EU Regulator Warns of 'Disappointing' Vaccine Booster Uptake
https://www.medscape.com/viewarticle/984585

Nov 28th, 2022 - (Reuters) - Recent uptake of COVID-19 vaccine booster doses in the European Union has been "rather disappointing," an official said on Thursday, amid concerns that protection against severe cases of the disease could weaken during the winter. The European average rate of re-vaccination, or receiving booster doses, was only 29% in the groups of people considered to be at highest risk, such as th...

5 Things to Know About This Early Flu Season From CDC's Lynnette Brammer, MPH
https://www.medscape.com/viewarticle/984449

Nov 28th, 2022 - 1. There's a lot of flu out there. According to the Centers for Disease Control and Prevention's FluView report, flu activity is elevated across the country, and flu hospitalization rates are the highest we have seen at this time in a decade. Hospitalization rates are highest among adults 65 years or older (18.6 per 100,000), followed by children younger than 5 years (13.6 per 100,000). Indicat...

Gavi Rejects Novavax's Claim on COVID Vaccine Deal Breach
https://www.medscape.com/viewarticle/984438

Nov 23rd, 2022 - (Reuters) - Global vaccine alliance Gavi on Tuesday rejected Novavax's claim that the group had breached an advance purchase agreement to procure 350 million doses of the company's COVID-19 vaccine. Novavax said on Monday that it had issued a notice to Gavi for terminating the agreement with immediate effect, citing the alliance's failure to procure the doses it had agreed to buy in May last ye...

White House's Jha: Social Media Platform Owners Should Consider Role in COVID Misinformation
https://www.medscape.com/viewarticle/984476

Nov 23rd, 2022 - WASHINGTON (Reuters) - Owners of social media platforms should consider their personal responsibility regarding health disinformation, and the public should choose reputable sources to trust, White House COVID-19 response coordinator Ashish Jha said on Tuesday. "You can decide to trust America's physicians, or you can trust some random dude on Twitter. Those are your choices," Jha said at a Whi...

Updated COVID Boosters Offer Better Protection Than Original: US Study
https://www.medscape.com/viewarticle/984485

Nov 23rd, 2022 - (Reuters) -Updated COVID-19 boosters offer increased protection against new coronavirus subvariants in people who have previously received up to four doses of the older vaccine, based on data from the first study to assess how the retooled shots are faring in the real world, U.S. officials said on Tuesday. The findings support results from company studies showing that their updated shots produc...

Fauci Pleads With Americans to Get COVID Shot in Final White House Briefing
https://www.medscape.com/viewarticle/984470

Nov 23rd, 2022 - WASHINGTON (Reuters) - Dr. Anthony Fauci, the U.S. health official celebrated and vilified as the face of the country's COVID-19 pandemic response, used his final White House briefing on Tuesday to denounce division and promote vaccines. Fauci, who plans to retire soon as President Joe Biden's top medical adviser and top U.S. infectious disease official, has dealt with the thorny questions arou...

Sick Call
https://www.medscape.com/viewarticle/984535

Nov 23rd, 2022 - They call me and I go. – William Carlos Williams I never get sick. I've never had the flu. When everyone's got a cold, I'm somehow immune. The last time I threw up was June 29th, 1980. You see, I work out almost daily, eat vegan, and sleep plenty. I drink gallons of pressed juice and throw down a few high-quality supplements. Yes, I'm that guy: The one who never gets sick. Well, I was anyway. D...

People Living With HIV Are a Model Population for Vaccination
https://www.medscape.com/viewarticle/984550

Nov 23rd, 2022 - TAMPA, Florida — People living with HIV (PLWH) were more likely than other populations to get vaccinated for flu and COVID-19, to seek reputable sources of information, and to be connected through essential community organizations that share essential health and wellness information, according to the results of a large survey. PLWH, therefore, would have been an ideal model population for creat...

EHR Reminders Boost Well-Child Visits, Vax Rates
https://www.medscape.com/viewarticle/984518

Nov 22nd, 2022 - Reminder messages sent through electronic health records (EHRs) to patient portals increased rates of scheduling and completion of well-child visits for those overdue for well care, as well as vaccination rates, according to data published today in JAMA Network Open. Anne E. Berset, BA, with general and community pediatrics at Cincinnati Children's Hospital, led a randomized clinical trial cond...

Fragmented Vax System Shifts PCP Role for Childhood Immunizations
https://www.medscape.com/viewarticle/984520

Nov 22nd, 2022 - Primary care physicians are missing key opportunities to discuss with parents the gamut of vaccinations their children should receive, a new survey has found. The COVID-19 pandemic has upended the usual delivery system for childhood vaccines, traditionally the province of pediatricians and other primary care providers, according to researchers at the University of Michigan, Ann Arbor. Some pare...

Novavax Ends COVID Vaccine Sale Agreement With Gavi
https://www.medscape.com/viewarticle/984424

Nov 22nd, 2022 - (Reuters) -Novavax Inc said on Monday it had delivered a written notice to Gavi, the Vaccine Alliance, terminating with immediate effect an agreement for the sale of the company's COVID-19 vaccine to low- and middle-income countries. The company cited Gavi's failure to procure the 350 million doses it had agreed to buy in May last year for the COVAX facility. The COVAX facility is a joint progr...

International Experts Recommend Actions to End the Pandemic
https://www.medscape.com/viewarticle/984442

Nov 22nd, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. SARS-CoV-2 still moves among us, requiring continued efforts and resources to save lives. This is the first of six themes outlined in an article published this month in Nature. A multidisciplinary panel of 386 experts from 112 countries and territories was convened to recommend specific actions ...

Myocarditis Appears Rare After COVID-19 Vaccination
https://www.medscape.com/viewarticle/984440

Nov 22nd, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The overall risk of developing myocarditis after COVID-19 vaccination is low, according to a new report from British Columbia, Canada. Because of certain risk factors, however, researchers recommended preferential use of the Pfizer–BioNTech vaccine over the Moderna vaccine for patients aged 18-2...